Yahoo Web Search

Search results

  1. Jun 14, 2024 · Neuromyelitis optica spectrum disorder (NMOSD) is a severe demyelinating diseases, which in seropositive cases, is caused by an autoantibody to the aquaporin-4 (AQP4) water channel.

    • devic's disease1
    • devic's disease2
    • devic's disease3
    • devic's disease4
    • devic's disease5
  2. Jun 17, 2024 · Current Rheumatology Reports. 2016. TLDR. It is recommended that every patient with NMOSD be started on an immunosuppressive agent, such as, azathioprine, methotrexate, or mycophenolate and in some cases, rituximab, soon after the acute attack and usually be treated for about 5 years after the attack. Expand.

  3. Jun 17, 2024 · Devic's disease, also known as neuromyelitis optica (NMO), is an uncommon autoimmune condition that affects the optic nerves and spinal cord. It is characterized by recurrent optic neuritis and myelitis, which can cause paralysis and visual impairment.

  4. Jun 20, 2024 · Neuromyelitis optica spectrum disorder was previously known as Devics disease, named after Devic and Gault, who first described the term neuromyelitis optics in 1894. The condition is more prevalent in females than males (9:1), and globally, NMOSD rarely occurs in five out of 100,000 cases.

  5. 3 days ago · Neuromyelitis optica, also known as Devic's disease, which affects the optic nerve(s) and spinal cord; Transverse myelitis, an autoimmune disorder that causes inflammation in the spinal cord; Acute disseminated encephalomyelitis (ADEM), an infection in the brain and spinal cord

    • Colleen Doherty, MD
    • 2 min
  6. Jun 13, 2024 · Information about neuromyelitis optica. About. NMOSD is a progressive autoimmune disease where the immune system mistakenly attacks nerve cells, affecting the nervous system. Learn more about the disease here. Discover. Causes. Scientists do not know the exact underlying cause of NMOSD.

  7. 4 days ago · Background. To date, most existing models for predicting neuromyelitis optica spectrum disorder (NMOSD) are based primarily on clinical characteristics. Blood-based NMOSD severity and prognostic predictive immune- and inflammation-related biomarkers are needed.

  1. People also search for